Drug class
Dopamine Agonists clinical trials
A class of medicines: the studies that test any of its 35 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the dopamine agonists studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
- Carbidopa, levodopa drug combination
- 53
- Benserazide, levodopa drug combination
- 3
- Piribedil
- 2
- Lisuride
- 2
- Aplindore
- 2
- Metergoline
- 1
- Ordopidine
- 1
- Dopexamine
- 1
Studies by the year they started
964 studies that test it; most in 2005 (64); 1 more planned to start later
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1995 | 1 |
| 1996 | 3 |
| 1998 | 4 |
| 1999 | 4 |
| 2000 | 8 |
| 2001 | 11 |
| 2002 | 20 |
| 2003 | 28 |
| 2004 | 59 |
| 2005 | 64 |
| 2006 | 63 |
| 2007 | 48 |
| 2008 | 52 |
| 2009 | 53 |
| 2010 | 46 |
| 2011 | 46 |
| 2012 | 52 |
| 2013 | 41 |
| 2014 | 39 |
| 2015 | 34 |
| 2016 | 24 |
| 2017 | 44 |
| 2018 | 40 |
| 2019 | 42 |
| 2020 | 16 |
| 2021 | 30 |
| 2022 | 22 |
| 2023 | 22 |
| 2024 | 14 |
| 2025 | 14 |
| 2026 | 19 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 507 · Other 461
Otsuka Pharmaceutical Development & Commercialization, Inc. (129) · UCB Pharma (38) · Boehringer Ingelheim (35) · Otsuka Pharmaceutical Co., Ltd. (30) · GlaxoSmithKline (19) · AbbVie (17) · Pfizer (16) · Knopp Biosciences (12)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 968
- Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic DepressionRecruitingPhase 3Daniel LindqvistNCT07664852Written as Pramipexole
- The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.Not yet recruitingPhase 2Washington University School of MedicineNCT07810738Written as Aripiprazole Augmentation
- Motor Network PhysiologyRecruitingNot applicableUniversity of Texas Southwestern Medical CenterNCT04957095Written as Apomorphine Injectable Solution
- Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast SymptomsRecruitingPhase 2Jefferson DrapkinNCT07492160Written as Cabergoline
- Cortical Electrophysiology of Response Inhibition in Parkinson's DiseaseRecruitingPhase 4Emory UniversityNCT06234995Written as Levodopa
- Gastrointestinal Dopamine Decarboxylase and Levodopa PharmacokineticsNot yet recruitingPhase 4Beth Israel Deaconess Medical CenterNCT07793461Written as Levodopa (L-dopa)
- Brexpiprazole Treatment for Bipolar I DepressionRecruitingPhase 3Douglas Mental Health University InstituteNCT04569448Written as Brexpiprazole
- Dopamine and Sensorimotor Function in StutteringRecruitingPhase 1University of California, San FranciscoNCT07215884Written as Aripiprazole 10 MG
- Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyRecruitingPhase 4Dennis M. McNamara, MD, MSNCT05180773Written as Bromocriptine
- Biomarkers to Enhance Early Schizophrenia TreatmentRecruitingPhase 4Northwell HealthNCT06969755Written as aripiprazole
- A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I DisorderRecruitingPhase 1/2Alzamend Neuro, Inc.NCT07540338Written as AL001
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRecruitingPhase 3Minerva NeurosciencesNCT07565428Written as aripiprazole
- Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in SchizophreniaNot yet recruitingPhase 1New York State Psychiatric InstituteNCT07715253Written as Brexpiprazole
- Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)Not yet recruitingPhase 2Christiana FrankeNCT07714213Written as Aripiprazole (low-dose, 1mg)
- Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)RecruitingPhase 4Nova Scotia Health AuthorityNCT05017311Written as Brexpiprazole
- Study of L-dopa Treatment in Patients With a Neurodevelopmental Disorder (CTNNB1 Gene)RecruitingNot applicableUniversity Hospital, MontpellierNCT07614126Written as L-Dopa
- Cerebellum-based Imaging Neural Markers for Antipsychotic ResponseRecruitingPhase 4Northwell HealthNCT07483294Written as aripiprazole
- Combination Osilodrostat and Cabergoline in Cushing's DiseaseEnrolling by invitationPhase 4University of BasrahNCT07603466Written as osilodrostat and cabergoline
- The Role of Brain Dopamine in Chronic PainRecruitingPhase 2University of RochesterNCT05285683Written as carbidopa-levodopa
- Stratified Pharmacological Approaches for Regulating Circuit-Level EffectsRecruitingPhase 2Stanford UniversityNCT07022405Written as Pramipexole Immediate Release
See all 968 studies that test one of the dopamine agonists →
Codes
What other systems call Dopamine Agonists · ClinicalTrials.gg INT008635
- MeSH (NLM) D018491Dopamine AgonistsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D018491 | Dopamine Agonists | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.